Marketing-authorisation holder
A.Forall Access Limited
5 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Cholecalciferol A.forall 20.000 IE zachte capsulesCapsule, zacht | Vitamin d | Netherlands | Authorised | 2022 |
| Cholecalciferol A.forall 25.000 IE zachte capsulesCapsule, zacht | Vitamin d | Netherlands | Authorised | 2022 |
| Dexamfetamine A.forall 10 mg tablettenTablet | Dexamfetamine | Netherlands | Authorised | 2026 |
| Dexamfetamine A.forall 20 mg tablettenTablet | Dexamfetamine | Netherlands | Authorised | 2026 |
| Dexamfetamine A.forall 5 mg tablettenTablet | Dexamfetamine | Netherlands | Authorised | 2026 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 5 | 5 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- PsychoanalepticsNervous system · ATC N06B
- VitaminsAlimentary tract and metabolism · ATC A11C
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- a forall access
- a forall access limited
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 5
- Countries
- 1
- Roles
- Authorisation holder